Ticks are one of the principal arthropod vectors of human and animal infectious diseases. Whereas the prevalence of tick-borne encephalitis virus in ticks in Europe is well studied, there is less information available on the prevalence of the other tick-borne viruses (TBVs) existing worldwide. The aim of this study was to improve the epidemiological survey tools of TBVs by the development of an efficient high-throughput test to screen a wide range of viruses in ticks. In this study, we developed a new high-throughput virus-detection assay based on parallel real-time PCRs on a microfluidic system, and used it to perform a large scale epidemiological survey screening for the presence of 21 TBVs in 18 135 nymphs of Ixodes ricinus collected from five European countries. This extensive investigation has (i) evaluated the prevalence of four Disease, 2018, Vol. 76, No. 8 viruses present in the collected ticks, (ii) allowed the identification of viruses in regions where they were previously undetected.
INTRODUCTION
Ticks are one of the principal arthropod vectors of human and animal infectious diseases and are able to transmit a wide range of bacteria, parasites and viruses (Gulia-Nuss et al. 2016) . Among the 900 tick species worldwide, Ixodes (I.) ricinus is the most widespread species in Europe, with the highest abundance. Ixodes ricinus is able to engorge on many different vertebrate hosts (Rizzoli et al. 2014; Egyed 2017 ) and transmits several pathogens of medical and veterinary importance. These include the spirochetes from the Borrelia genus which are the cause of Lyme borreliosis and relapsing fever borreliosis, the bacteria Anaplasma phagocytophilum responsible for human granulocytic anaplasmosis (HGA), parasites from the Babesia genus responsible for piroplasmosis and tick-borne viruses (TBVs) including tick-borne encephalitis virus (TBEV), louping ill virus (LIV), uukuniemi virus (UUKV), kemerovo virus and eyach virus (EYAV) (de la Fuente et al. 2008; Dantas-Torres, Chomel and Otranto 2012; Nuttall 2014; Rizzoli et al. 2014) .
Whereas bacteria and parasites incidences in animals, humans and ticks are well studied, there is less information available on viruses. Environmental changes, human travel and animal transportation have led to the emergence and/or the geographical expansion of several tick-borne pathogens (TBPs) worldwide including viruses (Dantas-Torres, Chomel and Otranto 2012; Lindgren et al. 2012; Jore et al. 2014; VayssierTaussat et al. 2015) . Several TBVs have already emerged in new territories, such as TBEV, LIV, powassan virus (POWV), deer tick virus and Crimean-Congo hemorrhagic fever virus (CCHFV) (Hinten et al. 2008; Mansfield et al. 2009; Maltezou et al. 2010) , while novel arthropod-borne viruses are constantly being discovered (Yu et al. 2011; McMullan et al. 2012; Tokarz et al. 2014a,b; Yun et al. 2014; Kosoy et al. 2015) . These trends highlight the importance of monitoring the distribution and prevalence of TBVs in European tick populations.
Whereas the prevalence of TBEV in ticks in Europe is well studied, there is less information available on the prevalence of other TBVs (Laaksonen et al. 2017; Raileanu et al. 2017; Rar et al. 2017; Zajac et al. 2017) . More than 500 arthropod-borne viruses are currently recognized worldwide (Bichaud et al. 2014) with at least 160 TBVs classified into nine different families: one DNA viral family, Asfarviridae and eight RNA viral families, Flaviviridae, Orthomyxoviridae, Reoviridae, Rhabdoviridae, the newly recognized Nyamiviridae (order Mononegavirales) and the families Nairoviridae, Phenuiviridae and Peribunyaviridae in the new order, Bunyavirales (Nuttall 2014; Kazimirova et al. 2017) .
Usually, TBV prevalence in ticks is estimated by RT-PCR or real-time RT-PCR (rRT-PCR) in assays which target specific viruses known (or suspected) to be present in the sample collection (Raileanu et al. 2017) . The disadvantage of this approach is the limited number of different viruses that can be tested, given the quantity of RNA required for one RT-PCR or rRT-PCR. The aim of this study was to improve the epidemiological survey tools of TBVs by the development of an efficient high-throughput test for screening of a wide range of viruses in ticks. For this purpose, we developed a novel high-throughput surveillance method based on real-time PCR which is able to identify 21 major worldwide TBVs in parallel in one sample. This assay based on a microfluidic system (BioMark TM dynamic array system, Fluidigm) is capable of performing 2304 individual real-time PCRs using 48.48 chips, using very small volumes of RNA for each individual PCR reaction (Michelet et al. 2014) . In a single experiment, 47 ticks or pools of ticks can be tested for the presence of 21 viruses, as well as confirmation of the tick species. A similar system has already been successfully developed to screen 37 tick-borne bacteria and parasites (Michelet et al. 2014 ). In the current study, we applied the new high-throughput assay to screen 18 135 I. ricinus collected from five European countries; Sweden, France, United Kingdom (UK), Denmark and the Netherlands. As a result, we have shown that high-throughput real-time PCRs to screen TBVs in European ticks appeared effective, both in terms of specificity and sensitivity. This new development opens novel perspectives in detection capacities that could potentially be applied to TBVs surveillance and large scale epidemiological studies.
MATERIALS AND METHODS

Study area and tick collection
A total of 18 135 I. ricinus nymphs, from 13 locations in five different countries were studied. Questing nymphs were collected using the flagging technique (Vassallo et al. 2000) in one location in UK and in three different locations in each of the four other countries ( Fig. 1) 
RNA extraction
Ticks were morphologically identified to species level (Pérez-Eid 2007) and preserved at −80
• C. After washing once in 70% ethanol for 5 min and twice in distilled water for 5 min, pools were crushed in 300 μl of DMEM with 10% fetal calf serum and six steel balls using the homogenizer Precellys R 24 Dual (Bertin, France) at 5500 rpm for 20 s or with one 5 mm steelball in the TissueLyser (Qiagen, Germany) at 30 Hz for 2 min. RNA was then extracted using the Nucleospin RNA II extract kit (Macherey-Nagel, Germany) using 100 μl of the homogenate. Two hundred microliter were conserved at −80
• C for back-up.
Total RNA per sample was eluted in 50 μl of RNase free water and stored at −80 • C until further use. For the Swedish samples the extraction was performed in a Magnatrix 8000+ robot using the Vet Viral NA kit (NorDiag, Sweden) according to the manufacturer's instructions.
Assay design
TBVs, their targeted genes and the corresponding primers/probe sets are listed in Table 1 . For each pathogen or tick, primers and probes were specifically designed for this study, except for CCHFV for which previously published primers and probes were used (reverse complement were used for probes) (Wolfel et al. 2007) . Nairobi Sheep Disease virus (NSDV) was targeted with two different set of primers and probe to improve detection. Each primer/probe set was validated using a dilution range of several RNA positive controls or synthetic plasmids (with inserts corresponding to the targeted sequence) ( 
Reverse transcription and cDNA pre-amplification
RNAs were transformed to cDNA by reverse transcription using the qScript cDNA Supermix kit according to the manufacturer's instructions (Quanta Biosciences, Beverly, USA). Briefly, the reaction was performed in a final volume of 5 μl containing 1 μl of qScript cDNA supermix 5 X, 1 μl of RNA and 3 μl of RNase free water; with one cycle at 25
• C for 5 min, one cycle at 42
• C for 30 min and one final cycle at 85
• C for 5 min.
For DNA pre-amplification, the Perfecta Preamp Supermix (Quanta Biosciences, Beverly, USA) was used according to the manufacturer's instructions. All primers were pooled to 200 nM final each. The reaction was performed in a final volume of 5 μl containing 1 μl Perfecta Preamp 5 X, 1.25 μl pooled primers, 1.5 μl distilled water and 1.25 μl cDNA, with one cycle at 95
• C for 2 min, 14 cycles at 95
• C for 10 s and 3 min at 60
• C. At the end of the cycling program, the reactions were 1:5 diluted. Pre-amplified cDNAs were stored at −20 • C until needed.
High-throughput real-time PCR
The BioMark TM real-time PCR system (Fluidigm, USA) was used for high-throughput microfluidic real-time PCR amplification using the 48.48 dynamic arrays (Fluidigm, USA). These chips dispense 48 PCR mixes and 48 samples into individual wells, after which on-chip microfluidics assemble PCR reactions in individual chambers prior to thermal cycling resulting in 2304 individual reactions.
Real-time PCRs were performed using FAM-and black hole quencher (BHQ1)-labeled TaqMan probes with TaqMan Gene Expression Master Mix in accordance with manufacturer's instructions (Applied Biosystems, France). Thermal cycling conditions were as follows: 2 min at 50
• C, 10 min at 95 • C, followed by 40 cycles of 2-step amplification of 15 s at 95
• C, and 1 min at 60
Data were acquired on the BioMark TM real-time PCR system and analyzed using the Fluidigm real-time PCR Analysis software to obtain C t values. See Michelet et al. 2014 for more detail. Primers and probes were evaluated for their specificity against RNA reference materials in quadruplicate or duplicate, and used in duplicate to screen field samples. One negative water control was included per chip. Ixodes ricinus RNA served to confirm the tested tick species and as a RNA extraction control. To determine if factors present in the sample could inhibit the PCR, Escherichia coli strain EDL933 DNA was added to each sample as an internal inhibition control, using primers and probe specific for the E. coli eae gene (Nielsen and Andersen 2003) .
EYAV detection in additional I. ricinus ticks from the Netherlands
RNA samples extracted from the 434 pools were screened for EYAV by classical real-time RT-PCR targeting the VP2 of the EYAV genome with specific primers and probes (Table 1) . Real-time RT-PCR Taqman assays were performed in a final volume of 20 μl using the LightCycler R 480 RNA Master Hydrolysis Probes master mix (Roche Applied Science, Germany) at 1 X final concentration, with 0.5 μM specific primers and 0.25 μM probes, 3.25 mM manganese acetate [Mn(OAc)2] and 2 μl RNA. Positive and negative (water) controls were included in each run. Real-time RT-PCR thermal cycling conditions were as follows: 63
• C for 3 min, 95
• C for 30 s, 45 cycles at 95 • C for 10 s then 60
• C for 30 s, followed by cooling at 40
• C for 10 s.
Validation of the results by RT-PCR, nested PCR and sequencing
Conventional RT-PCR followed (or not) by nested PCR using primers targeting different genes or regions than those of the BioMark TM system (Table 2) , were used to confirm the presence of viral RNA in the field samples. Amplicons were sequenced by Eurofins MWG Operon (Germany), and then assembled using BioEdit software (Ibis Biosciences, Carlsbad). An online BLAST (National Center for Biotechnology Information) was used to compare results with published sequences listed in GenBank sequence databases.
Prevalence estimation
Prevalences were estimated assuming perfect sensitivity and specificity of pathogen detection using the online statistical program "Pooled prevalence for fixed pool size and perfect test" Method 2 (AusVet Animal Health Service http://epitools.ausvet. com.au/content.php?page = home). If all 45 pools of 31 nymphs were negative, prevalence was recorded as < 0.21%, because the 95% probability of sampling n (1395) negative ticks from a population with prevalence p is given as (1-p)n.
RESULTS
Primer/probe sets were specifically designed to detect 21 TBV and two tick species (Table 1) . Each set of primers/probe specifically identified their corresponding positive control samples (tick species or viral RNA or plasmid with the sequence of interest) via Taqman RT-real-time PCRs or Taqman real time PCRs on a LightCycler 480 apparatus, except for the two designs targeting NSDV. Resulting C t values varied from 8 to 40 depending on sample type and nucleic acid concentration. To avoid sensitivity problems, a step of cDNA pre-amplification was included in the assay. The usefulness of such a pre-amplification step has already been demonstrated for the detection of 37 TBPs (bacteria and parasites) using with the same system and allowed specific amplification of the targeted pathogen sequences [24] . Indeed, this step enabled detection of all positive controls via Taqman real time PCRs on a LC480 apparatus, again except for the two NSDV designs. Those designs were deleted from the chip for the rest of the analysis. The specificity of each primers/probe set was then evaluated using 34 TBV positive controls (different strains of each virus when possible or plasmid) on the BioMark TM system (Fig. 2) . Results demonstrated high specificity for each primer/probe set after pre-amplification (Fig. 2) . Indeed, 20 assays (on the 21 developed) were only positive for their corresponding positive controls. The assay for POWV showed crossreactivity with deer tick virus. A total of 18 135 nymphs, in 45 pools of 31 nymphs per site, from 13 European locations (five countries) were tested using the new assay on the BioMark TM system. Among the targeted viruses, 17 were not detected in ticks from any country (TBEV eastern subtype, TBEV Siberian subtype, langat, LIV, deer tick, POWV, meaban, West Nile, Kyasanur, Omsk, African swine fever, thogoto, dhori, Kemerovo, Colorado tick fever virus, dugbe, Table 3 .
1/TBEV
TBE virus was detected in four pools from Sweden at the HR site with a prevalence of 0.30%. The four sequences obtained presented 100% identity, one sequence was deposited in GenBank (accession number: MH708169) and showed 98% homology with reference sequences from European subtype strains isolated in ticks (Italy, GenBank FJ159003), rodent (Finland, GenBank GU183380) and human sera (Czech Republic, GenBank KJ922515) ( 
2/UUKV
UUKV was detected in five pools in Sweden with a prevalence of 0.22% for HR site and 0.07% for MH and RV sites. The virus was also detected in two pools in the Netherlands (site K) with a prevalence of 0.15%. In total UUKV was detected in seven pools from Europe. Sequences obtained for the S segments (accession numbers: MH708178-MH708180 Sweden, MH708181-MH708182 the Netherlands) presented 99% (K site, the Netherlands) and 97% (HR site, Sweden) with Uukuniemi S segment (GenBank M33551 and KM114248, respectively). Sequences obtained for L segments (accession numbers: MH708173 the Netherlands, MH708174-MH708177 Sweden) presented between 94% and 97% homology with Uukuniemi L segment (GenBank D10759) ( Table 4) .
3/EYAV
EYAV was detected in five pools from the Netherlands at the K site with a prevalence of 0.38%. To confirm the presence of the virus in the Netherlands, 291 adult and 1167 nymphal ticks were collected from five locations in the province of Overijssel. Among the 434 pools, only one nymphal pool was positive for EYAV (Prevalence 0.07% [0.002-0.403]). Sequences obtained from site K were 100% identical (accession number: MH708170) and presented 95% homology with an Eyach virus-VP12 sequence available in GenBank (AF343061). Sequences obtained from Overijssel province (accession number: MH708171-MH708172) presented 99% and 97% homology, respectively, with two Eyach virus-VP1 sequences available in GenBank (AF282467 and AF343053) ( Table 4) .
4/New-Nairovirus
One pool of ticks collected at the S site in France and two pools collected at the D site in the Netherlands were found positive for CCHF virus, with a prevalence of 0.07% and 0.15%, respectively. A nested PCR targeting the N gene of CCHF virus was attempted on positive samples but failed to amplify a sequence of interest. However, a nested PCR targeting the S segment of viruses from the Nairovirus genus was tested on the three samples. An amplification product was obtained for one positive sample from D site (the Netherlands) when cDNAs were diluted at 1 to 5 before being assessed by nested PCR, and a band of 400 bp was visualized on an agarose gel for this sample (Fig. 3) . The PCR product was send for sequencing but the sequence obtained was not readable, so the sequence failed. Unfortunately, no more RNA or tick homogenate were available to perform further analysis. 
DISCUSSION
In this study, we developed and tested in field a new highthroughput virus-detection assay based on microfluidic PCRs. Subsequently, we used this newly developed assay to perform a large scale epidemiological survey screening for the presence of 21 TBVs in 18 135 nymphs of I. ricinus collected from 13 European sites (one in UK, and three in France, Denmark, Sweden and the Netherlands). This large investigation has (i) evaluated the prevalence of four viruses present in the collected ticks, (ii) allowed the detection of UUKV for the first time in Sweden and UUKV and EYAV for the first time in the Netherlands and (iii) detected a potential new-Nairovirus in ticks from France and the Netherlands. Despite a pre-amplification step, two designs targeting NSDV were unable to detect the RNA positive controls used in this study. This failure suggests degradation of this RNA sample, unfortunately we were not able to obtain another positive control. Confirmation of the sensitivity of these two primer/probe sets needs to be undertaken in the future at least using a plasmid with the sequence of interest. Among the others sets of primer/probe, 13 allowed the detection of their targeted viral RNA with controls. For eight viruses, RNA positive controls were not available and plasmids containing targeted sequences have been used. For those viruses, and associated primer/probe sets, further evaluation of specificity is required.
In our study, we screened 18 135 I. ricinus nymphs collected in 13 European sites for the presence of 21 TBVs and four viruses' prevalences were estimated (Table 3) .
TBEV was only detected in one site in Sweden with a prevalence of 0.29%. TBEV causes severe central nervous system infection in 15 000 people in Europe and Asia each year (Dobler 2010) . Three subtypes of this virus exist: European (transmitted by I. ricinus), Siberian and Far Eastern (transmitted by I. persulcatus); which present a geographical distribution globally linked to their name (Mansfield et al. 2009; Simmonds et al. 2012; Nuttall 2014) . The distinctive characteristic of TBEV distribution inside each country is its focal pattern, each focus representing a hotspot of virus circulation (Dobler et al. 2011; Suss 2011) . TBE is endemic in south-central Sweden, with the highest number of TBEV foci present in the Stockholm archipelago (Pettersson et al. 2014) . Prevalence of ticks for TBEV in our study is close to the one previously estimated in northern Europe (Denmark, 
a ASFV: African swine fever virus; TBEV: Tick-borne encephalitis virus; CCHFV: Crimean-Congo Hemorrhagic fever virus; a All pools negative. If all 45 pools of 31 nymphs were negative, prevalence was recorded as < 0.21%, because the 95% probability of sampling n negative ticks from a population with prevalence p is given as (1-p)n. (Asghar et al. 2017) . In our study, TBEV was detected in the south-west of Sweden (HR site) in a recently affected TBE area. Indeed, TBEV has been spreading south west from the original focus in the Stockholm area during the last 20 yr (Lundkvist et al. 2011) . No TBEV or LIV infected ticks have been detected in our study in France, Denmark, UK and the Netherlands even if TBE and LIV viruses are known to circulate in those countries (Laursen and Knudsen 2003; Hansmann et al. 2006; Fomsgaard, Christiansen and Bodker 2009; Suss 2011; Gilbert 2016; Levy et al. 2016; Jahfari et al. 2017) . Nevertheless, the prevalence of these viruses in ticks is usually low, and virus detection occurs mainly in local foci where the virus is known to circulate (Perez-Eid, Hannoun and Rodhain 1992; Fomsgaard, Christiansen and Bodker 2009; Jeffries et al. 2014; Jahfari et al. 2017) .
UUKV was detected in three sites in Sweden with a prevalence ranging between 0.07% and 0.22% and in one site in the Netherlands with a prevalence of 0.15%. UUKV was originally isolated at Uukuniemi (southern Finland) in 1979 from I. ricinus collected from cattle (Oker-Blom et al. 1964) . This virus is maintained in nature between its tick vector, I. ricinus, and its vertebrate hosts, forest rodents and birds (Hubalek and Rudolf 2012) . No animal or human disease due to this virus has yet been reported (Hubalek and Rudolf 2012) . This virus is known to circulate in northern Europe (Norway and Finland), and eastern Europe (Hubalek and Rudolf 2012) . Nevertheless, to our knowledge, this is the first report of UUKV in ticks in Sweden and in the Netherlands, although the virus is known to be present in neighboring and/or close countries. Birds and migratory birds may have played a role in the dispersion of the virus, and indeed several strains of UUKV have been isolated from immature I. ricinus collected on migratory passerines (Traavik 1979) . Sequences obtained during our study for L and S segments showed 94% to 97% and 97% to 99% homology with UUKV L and S segments isolated from ticks in Finland and Czech Republic (GenBank D10759, KM114248 and M33551). Nevertheless, it appears difficult to evaluate the genetic diversity of this virus in the field due to the few numbers of sequences available in GenBank (Mazelier et al. 2016) .
EYAV was detected from one site in the Netherlands with a prevalence of 0.38%. The presence of this virus in the Netherlands was confirmed by screening 291 adult and 1167 nymphal ticks collected from five locations in the province of Overijssel. Of these, one nymphal pool was positive for EYAV. Sequences obtained showed 95% to 99% homology with Eyach virus sequence (GenBank AF343061, AF282467-AF343053), nevertheless only few sequences are available in GenBank avoiding studies on the genetic diversity of this virus in field samples. EYAV was first isolated from I. ricinus ticks in Germany in 1972, followed by isolations from two tick species in France in 1981, I. ventalloi and I. ricinus (Rehse-Kupper et al. 1976; Chastel et al. 1984) . This virus has subsequently remained undetected for the next 30 yr, before being detected in two regions from France in 2010 and 2012 in I. ricinus ticks with a prevalence comprised between 0.07% and 5.26% (Moutailler et al. 2016) . EYAV has been indirectly linked to cases of encephalitis and polyradiculoneuritis in former Czechoslovakia (Malkova et al. 1980) , and Moutailler et al. have demonstrated the ability of EYAV to reach the brain of new suckling mice after intraperitoneal inoculation, indicating the ability of the virus to multiply in vertebrate hosts (Moutailler et al. 2016) . Nevertheless, until now, no viral RNA has been isolated from animals or humans, even if anti-Eyach virus antibodies have been identified in many animal species in France (European rabbit [Oryctolagus cuniculus], rodents, sheep, deer and mountain goats) (Chastel 1998; Attoui et al. 2002) . Thus, specific detection of this virus in patients presenting with encephalitis could lead to an improved evaluation of its prevalence in humans in Europe.
CCHF-like virus was detected in one pool from France (S site) and two pools from the Netherlands (D site) with a prevalence of 0.07% and 0.15% respectively. A nested PCR specific to CCHF virus failed to confirm this result, although a nested PCR specific to Nairovirus genus produced one band at the expected size and was sent for sequencing. Unfortunately, no readable sequence was obtained to confirm our findings. The primers/probes set used in the microfluidic system was taken from the literature without modification and is used to detect CCHFV in patients (Wolfel et al. 2007 ). However, our results suggest an ability of this primers/probes set to also detect other viruses from the Nairovirus genus in ticks, and tentatively named potential newNairovirus. CCHFV is a hemorrhagic virus with high public health concern in Europe, as this virus has emerged in numerous eastern and southern European countries in the last decades. Recently, fatal autochthonous human cases have been observed in Spain, but this virus is usually transmitted by Hyalomma spp. ticks (Maltezou et al. 2010; Al-Abri et al. 2017; Negredo et al. 2017) . Nevertheless, new Nairovirus sequences have been detected in ticks, e.g. I. ricinus, in different studies, demonstrating the risk of misidentification of CCHFV presence in European ticks (Tokarz et al. 2014b; Xia et al. 2015; Moutailler et al. 2016 , Shimada et al. 2016 . To conclude, CCHFV prevalence studies in ticks should always confirm their findings by sequencing to avoid misinterpretation, as Orkun and collaborators did in a large scale survey performed on different tick species collected from different areas in Turkey (Orkun et al. 2017) . As a consequence of our findings and to avoid misidentification of CCHF virus, a new set of primers/probe specific for this virus will be implemented in the PCR chip and the old set will be conserved as a Nairovirus genus specific one.
In our study, 17 viruses were not detected in the 18 135 I. ricinus nymphs collected in 13 European sites. This result is not surprising as a large part of those viruses are not known to be present in Europe, e.g. deer tick virus, powassan virus, etc. . . , or not known to be transmitted by I. ricinus ticks, e.g. Kyasanur forest disease virus, African swine fever virus, dhori virus, etc. . . .Nevertheless, a more extensive survey is needed to confirm our findings regarding the absence of European viruses usually transmitted by I. ricinus, e.g. Kemerovo virus, louping ill virus, etc. . . , in the five European countries studied in this project.
This study demonstrates the feasibility of high-throughput screening methods to enable the detection of numerous TBVs in ticks, often less studied than other TBPs (TBPs) such as bacteria and parasites. Other high-throughput techniques (metagenomics methods) exist such as Whole Genome Sequencing (WGS, RNA sequencing) (Moutailler et al. 2016) or resequencing array, but they are often time consuming, expensive and require specialized bioinformatics tools. Moreover, those techniques, often performed on pools, bear some weakness such as the lack of TBV prevalence estimation. Metagenomics microarray technology has also been developed to allow rapid simultaneous identification of all known viruses but also all virus families (within hours) in clinical samples (Erlandsson et al. 2011; Rosenstierne et al. 2014; Fridholm et al. 2016) . This technique should be tested on tick samples to investigate its ability to be used for epidemiological surveys. Nevertheless, the main advantage of the microfluidic system-based real-time PCR is that new sets of primers and probes targeting newly emergent viruses can easily be added to the assay, in contrast to arrays with fixed panels of probes. As an example, the recent emergence of Heartland and Bourbon viruses in USA (McMullan et al. 2012; Kosoy et al. 2015) and Severe fever with thrombocytopenia syndrome virus (SFTSV) in Asia (Yu et al. 2011; Yun et al. 2014 ) has led us to add primer/probe sets specific for these viruses to our panel of primers/probe sets, and are currently being used in novel large scale epidemiological surveys of TBVs in ticks.
In conclusion, our study describes a real-time RT-PCR approach based on a microfluidic system allowing multiple assays in parallel. The method is designed to specifically identify TBVs in European ticks. We demonstrated the capabilities of this new screening method that allows the detection of numerous TBVs in numerous tick and/or host samples, and the identification of viruses in regions where they were previously undetected. This tool represents a powerful, and a more rapid system compared to classical real-time PCRs, for TBVs surveillance in Europe and could be easily customized to assess viral emergence. 
